Is Cellectar Biosciences Inc (CLRB) Stock a Good Value Thursday?

Cellectar Biosciences Inc (CLRB) is near the top in its sector according to InvestorsObserver. CLRB gets an overall rating of 83. That means it scores higher than 83% of stocks. Cellectar Biosciences Inc gets a 98 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

CLRB has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on CLRB!

See Full CLRB Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 83 would rank higher than 83 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cellectar Biosciences Inc Stock Today?

Cellectar Biosciences Inc (CLRB) stock is trading at $3.84 as of 11:50 AM on Thursday, Mar 21, a rise of $0.11, or 2.95% from the previous closing price of $3.73. The stock has traded between $3.76 and $3.96 so far today. Volume today is low. So far 336,486 shares have traded compared to average volume of 1,030,550 shares. Click Here to get the full Stock Report for Cellectar Biosciences Inc stock.